| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |